Core Scientific (CORZ) Projected to Post Quarterly Earnings on Wednesday

Core Scientific (NASDAQ:CORZGet Free Report) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect Core Scientific to post earnings of ($0.27) per share and revenue of $118.4460 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, March 6, 2026 at 9:30 AM ET.

Core Scientific Price Performance

NASDAQ:CORZ opened at $17.30 on Monday. Core Scientific has a 12-month low of $6.20 and a 12-month high of $23.63. The business has a 50 day simple moving average of $16.98 and a 200 day simple moving average of $16.83. The firm has a market capitalization of $5.36 billion, a P/E ratio of 115.34 and a beta of 6.85.

Hedge Funds Weigh In On Core Scientific

A number of hedge funds have recently modified their holdings of CORZ. Value Aligned Research Advisors LLC purchased a new stake in shares of Core Scientific during the fourth quarter valued at $117,786,000. Situational Awareness LP increased its stake in Core Scientific by 76.8% in the 2nd quarter. Situational Awareness LP now owns 7,994,038 shares of the company’s stock worth $136,458,000 after purchasing an additional 3,472,460 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Core Scientific by 584.2% during the 4th quarter. JPMorgan Chase & Co. now owns 3,689,053 shares of the company’s stock worth $53,713,000 after buying an additional 3,149,859 shares during the period. Goodlander Investment Management LLC acquired a new stake in Core Scientific during the 2nd quarter worth about $34,994,000. Finally, Northern Right Capital Management L.P. lifted its stake in Core Scientific by 1,048.9% during the second quarter. Northern Right Capital Management L.P. now owns 1,723,422 shares of the company’s stock valued at $29,419,000 after buying an additional 1,573,422 shares in the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target for the company in a report on Thursday, December 18th. Jefferies Financial Group set a $24.00 price objective on shares of Core Scientific and gave the company a “buy” rating in a research report on Tuesday, October 28th. Zacks Research upgraded shares of Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. Craig Hallum set a $27.00 price target on shares of Core Scientific in a research note on Friday, October 31st. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $24.21.

Read Our Latest Analysis on Core Scientific

About Core Scientific

(Get Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Featured Stories

Earnings History for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.